Mushtaq, M., Liaño-Pons, J., Wang, J., Alzrigat, M., Yuan, Y., Ruiz-Pérez, M. V., Chen, Y., Kashuba, E., Haglund de Flon, F., Brodin, B., & Arsenian-Henriksson, M. (2024). EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma. Cell Death & Disease, 15(11). https://doi.org/10.1038/s41419-024-07176-6

Chen, Y., Su, Y., Cao, X., Siavelis, I., Leo, I. R., Zeng, J., Tsagkozis, P., Hesla, A. C., Papakonstantinou, A., Liu, X., Huang, W., Zhao, B., Haglund, C., Ehnman, M., Johansson, H., Lin, Y., Lehtiö, J., Zhang, Y., Larsson, O., … de Flon, F. H. (2024). Molecular Profiling Defines Three Subtypes of Synovial Sarcoma. Advanced Science, 11(41). Portico. https://doi.org/10.1002/advs.202404510

D’Angelo, S. P., Araujo, D. M., Abdul Razak, A. R., Agulnik, M., Attia, S., Blay, J.-Y., Carrasco Garcia, I., Charlson, J. A., Choy, E., Demetri, G. D., Druta, M., Forcade, E., Ganjoo, K. N., Glod, J., Keedy, V. L., Le Cesne, A., Liebner, D. A., Moreno, V., Pollack, S. M., … Van Tine, B. A. (2024). Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. The Lancet, 403(10435), 1460–1471. https://doi.org/10.1016/s0140-6736(24)00319-2

Tordjman, M., Honoré, C., Crombé, A., Bouhamama, A., Feydy, A., Dercle, L., Haddag, L., Bouché, P.-A., Ngo, C., Le Cesne, A., Blay, J.-Y., Mir, O., Brahmi, M., Martin, C., Karanian, M., Ammari, S., Kind, M., Audard, V., Le Loarer, F., … Mihoubi, F. (2022). Prognostic factors of the synovial sarcoma of the extremities: imaging does matter. European Radiology, 33(2), 1162–1173. https://doi.org/10.1007/s00330-022-09049-y